STGT invests 11 B Baht to expand production of gloves in Thailand owing to COVID-19 biospectrumasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumasia.com Daily Mail and Mail on Sunday newspapers.
Merck invests ⬠250M in new biotech development centre in Switzerland
Merck invests ⬠250M in new biotech development centre in Switzerland 07 July 2021 | News
image credit- businesswire
German firm Merck has announced the topping-out ceremony for its new Biotech Development Center in Corsier-sur-Vevey, Switzerland.
This investment of € 250 million, which was announced in January 2020, is intended to help secure the capacities for a cost-efficient and agile provision of clinical study medication in the long term, to shorten the development time of novel biological active ingredients and to meet the challenge of the increasingly complex production of biotechnological substances to master the next generation.
Korea approves first anti-COVID-19 monoclonal antibody treatment 08 February 2021 | News CT-P59 is approved for the treatment of patients aged 60 years and over, or with at least one underlying medical condition, with mild symptoms of COVID-19, and adult patients with moderate symptoms of COVID- 19
Photo Credit: Freepik
Celltrion Group has announced that the Ministry of Food and Drug Safety (MFDS) of South Korea has granted conditional marketing authorization (MA) for the emergency use of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment candidate. Conditional Marketing Authorization allows emergency use of CT-P59 in adult patients aged 60 years and over, or with at least one underlying medical condition (cardiovascular, chronic respiratory disease, diabetes, elevated blood pressure) mild symptoms of COVID-19, and in adult patients with moderate symptoms of COVID-19.